UBS Group AG - HOTH THERAPEUTICS INC ownership

HOTH THERAPEUTICS INC's ticker is and the CUSIP is 44148G204. A total of 12 filers reported holding HOTH THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of HOTH THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,308
-51.0%
4,150
-3.4%
0.00%
Q2 2023$12,882
-29.2%
4,294
-51.4%
0.00%
Q1 2023$18,186
-41.4%
8,828
+121.9%
0.00%
Q4 2022$31,0363,9790.00%
Other shareholders
HOTH THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 140,000$1,092,0000.02%
Tower Research Capital LLC (TRC) 2,229$180.00%
HRT FINANCIAL LP 11,532$890.00%
JANE STREET GROUP, LLC 11,122$86,7520.00%
UBS Group AG 3,979$31,0360.00%
OSAIC HOLDINGS, INC. 4$00.00%
FMR LLC 1$80.00%
WELLS FARGO & COMPANY/MN 9$700.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 2$160.00%
View complete list of HOTH THERAPEUTICS INC shareholders